Anna L. Rényi

2.3k total citations
29 papers, 1.9k citations indexed

About

Anna L. Rényi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Anna L. Rényi has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Anna L. Rényi's work include Neurotransmitter Receptor Influence on Behavior (15 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Ion channel regulation and function (8 papers). Anna L. Rényi is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (15 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Ion channel regulation and function (8 papers). Anna L. Rényi collaborates with scholars based in Sweden. Anna L. Rényi's co-authors include Svante B. Ross, Sven Ove Ögren, Håkan Hall, H�kan Hall, Douglas Westerlund, Stefan Bengtsson, Nils E. Stjernström, L. E. B. Johansson and Tomas de Paulis and has published in prestigious journals such as Journal of Medicinal Chemistry, Life Sciences and Psychopharmacology.

In The Last Decade

Anna L. Rényi

29 papers receiving 1.7k citations

Peers

Anna L. Rényi
W.P. Burkard Switzerland
Harold D. Snoddy United States
H. H. Keller Switzerland
Nicholas J. Giarman United States
Albert Weissman United States
A. V. Christensen Denmark
Michael S. Eison United States
Michael S. Briley France
William O. Boggan United States
Philippe Protais France
W.P. Burkard Switzerland
Anna L. Rényi
Citations per year, relative to Anna L. Rényi Anna L. Rényi (= 1×) peers W.P. Burkard

Countries citing papers authored by Anna L. Rényi

Since Specialization
Citations

This map shows the geographic impact of Anna L. Rényi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Rényi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Rényi more than expected).

Fields of papers citing papers by Anna L. Rényi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Rényi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Rényi. The network helps show where Anna L. Rényi may publish in the future.

Co-authorship network of co-authors of Anna L. Rényi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Rényi. A scholar is included among the top collaborators of Anna L. Rényi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Rényi. Anna L. Rényi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ross, Svante B., H�kan Hall, Anna L. Rényi, & Douglas Westerlund. (1981). Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat. Psychopharmacology. 72(3). 219–225. 60 indexed citations
2.
Rényi, Anna L., et al.. (1981). Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake. Journal of Medicinal Chemistry. 24(12). 1499–1507. 17 indexed citations
3.
Ögren, Sven Ove, et al.. (1981). The pharmacology of zimelidine: A 5‐HT selective reuptake inhibitor. Acta Psychiatrica Scandinavica. 63(s290). 127–151. 94 indexed citations
4.
Ögren, Sven Ove, et al.. (1980). Anti‐aggressive Effect of Zimelidine in Isolated Mice. Acta Pharmacologica et Toxicologica. 47(1). 71–74. 25 indexed citations
5.
Rényi, Anna L., et al.. (1978). Antidepressant agents. 9. 3,3-Diphenylcyclobutylamines, a new class of central stimulants. Journal of Medicinal Chemistry. 21(1). 78–82. 7 indexed citations
6.
Bengtsson, Stefan, et al.. (1978). Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by .alpha.-amino acid esters of phenethyl alcohols. Journal of Medicinal Chemistry. 21(5). 448–456. 82 indexed citations
7.
Ross, Svante B. & Anna L. Rényi. (1978). Effect of (+)‐Amphetamine on the Retention of 3H‐Catecholamines in Slices of Normal and Reserpinized Rat Brain and Heart. Acta Pharmacologica et Toxicologica. 42(5). 328–336. 14 indexed citations
8.
Ross, Svante B., Sven Ove Ögren, & Anna L. Rényi. (1977). Substituted Amphetamine Derivatives. I. Effect on Uptake and Release of Biogenic Monoamines and on Monoamine Oxidase in the Mouse Brain. Acta Pharmacologica et Toxicologica. 41(4). 337–352. 21 indexed citations
9.
10.
Johansson, L. E. B., Tomas de Paulis, Nils E. Stjernström, et al.. (1974). Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro[5H-dibenzo[a,d]cycloheptene-5,1'-cycloalkanes]. Journal of Medicinal Chemistry. 17(1). 65–72. 10 indexed citations
11.
Ross, Svante B., et al.. (1974). Long-term effects of N-hydroxy-4-chloroamphetamine on the level and accumulation of 5-hydroxytryptamine in the rat brain. European Journal of Pharmacology. 28(1). 222–224. 5 indexed citations
12.
Ross, Svante B., Anna L. Rényi, & Sven Ove Ögren. (1972). Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine. European Journal of Pharmacology. 17(1). 107–112. 54 indexed citations
13.
Ross, Svante B., Anna L. Rényi, & Sven Ove Ögren. (1971). A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices. Life Sciences. 10(22). 1267–1277. 73 indexed citations
14.
Ross, Svante B. & Anna L. Rényi. (1969). Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. European Journal of Pharmacology. 7(3). 270–277. 274 indexed citations
15.
Ross, Svante B. & Anna L. Rényi. (1967). Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sciences. 6(13). 1407–1415. 107 indexed citations
16.
Ross, Svante B. & Anna L. Rényi. (1967). Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. European Journal of Pharmacology. 2(3). 181–186. 223 indexed citations
17.
Ross, Svante B. & Anna L. Rényi. (1966). Active uptake of tritiated metaraminol by mouse brain slices. Life Sciences. 5(7). 639–647. 6 indexed citations
18.
Ross, Svante B. & Anna L. Rényi. (1966). In Vitro Inhibition of Noradrenaline‐3H Uptake by Reserpine and Tetrabenazine in Mouse Cerebral Cortex Tissues. Acta Pharmacologica et Toxicologica. 24(1). 73–88. 7 indexed citations
19.
Ross, Svante B. & Anna L. Rényi. (1966). Uptake of tritiated tyramine and (+)-amphetamine by mouse heart slices. Journal of Pharmacy and Pharmacology. 18(11). 756–757. 14 indexed citations
20.
Ross, Svante B. & Anna L. Rényi. (1964). Blocking Action of Sympathomimetic Amines on the Uptake of Tritiated Noradrenaline by Mouse Cerebral Cortex TissuesIn Vitro.. Acta Pharmacologica et Toxicologica. 21(3). 226–239. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.P. Burkard Breakdown of academic impact, for papers by Harold D. Snoddy Breakdown of academic impact, for papers by H. H. Keller Breakdown of academic impact, for papers by Nicholas J. Giarman Breakdown of academic impact, for papers by Albert Weissman Breakdown of academic impact, for papers by A. V. Christensen Breakdown of academic impact, for papers by Michael S. Eison Breakdown of academic impact, for papers by Michael S. Briley Breakdown of academic impact, for papers by William O. Boggan Breakdown of academic impact, for papers by Philippe Protais
Rankless by CCL
2026